PSP Research LLC
- SEC CIK
- 0002106939
- Latest filing
- Jul 9, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Jul 9, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 75
- −4 vs. Q1 2026
- Portfolio value
- $187.9M
- +$46.6M (+32.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 570,000 | $90.2M | 48.0% | +285,100+100.1% | Added | – |
| iShares Tr46436E718 | 0-3 MTH TREASURY | 700,000 | $70.5M | 37.5% | 00.0% | Unchanged | – |
| RPRXRoyalty Pharma plc | SHS CLASS A | 11,000 | $616.8K | 0.3% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 25,000 | $606.5K | 0.3% | −3,700−12.9% | Reduced | History |
| INCYIncyte Corp | COM | 5,300 | $600.8K | 0.3% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 641 | $594.7K | 0.3% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 8,000 | $585.1K | 0.3% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 14,000 | $583.4K | 0.3% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 17,000 | $567.6K | 0.3% | −5,100−23.1% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 30,000 | $559.5K | 0.3% | 00.0% | Unchanged | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 23,000 | $556.6K | 0.3% | −5,000−17.9% | Reduced | History |
| TGTXTG Therapeutics, Inc. | COM | 10,000 | $549.4K | 0.3% | −3,000−23.1% | Reduced | History |
| HALOHalozyme Therapeutics, Inc. | COM | 7,000 | $547.9K | 0.3% | −1,026−12.8% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 6,800 | $539.2K | 0.3% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 15,000 | $518.7K | 0.3% | −5,000−25.0% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 19,700 | $516.5K | 0.3% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 30,000 | $509.1K | 0.3% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,000 | $505.6K | 0.3% | −848−22.0% | Reduced | History |
| IMVTImmunovant, Inc. | COM | 13,000 | $500.9K | 0.3% | −6,200−32.3% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 19,766 | $500.1K | 0.3% | 00.0% | Unchanged | History |
| PTCTPTC Therapeutics, Inc. | COM | 6,000 | $489.4K | 0.3% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 13,000 | $483.7K | 0.3% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 15,141 | $480.7K | 0.3% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 10,000 | $470.4K | 0.3% | −24,800−71.3% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 12,000 | $464.4K | 0.2% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 4,000 | $458.7K | 0.2% | −2,300−36.5% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 20,000 | $444.2K | 0.2% | 00.0% | Unchanged | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,465 | $441.0K | 0.2% | 00.0% | Unchanged | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 7,000 | $440.6K | 0.2% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 20,000 | $437.2K | 0.2% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 8,000 | $435.3K | 0.2% | −3,948−33.0% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 11,000 | $411.6K | 0.2% | 00.0% | Unchanged | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 12,000 | $406.7K | 0.2% | −3,000−20.0% | Reduced | History |
| ASNDAscendis Pharma A/S | ORD SHS | 1,500 | $400.1K | 0.2% | −1,000−40.0% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 5,000 | $398.6K | 0.2% | +5,000 | New | History |
| STOKStoke Therapeutics, Inc. | COM | 12,000 | $392.6K | 0.2% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 10,000 | $390.1K | 0.2% | −5,000−33.3% | Reduced | History |
| IMNMImmunome Inc. | COM | 18,000 | $381.4K | 0.2% | −2,000−10.0% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 3,000 | $367.7K | 0.2% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 10,000 | $364.1K | 0.2% | −4,283−30.0% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 7,000 | $355.3K | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 4,000 | $355.1K | 0.2% | −1,159−22.5% | Reduced | History |
| NTLAIntellia Therapeutics, Inc. | COM | 20,000 | $338.4K | 0.2% | −6,900−25.7% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 600 | $322.2K | 0.2% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 5,000 | $319.8K | 0.2% | −4,000−44.4% | Reduced | History |
| ALKSAlkermes plc. | SHS | 6,000 | $314.4K | 0.2% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 10,000 | $312.6K | 0.2% | −4,400−30.6% | Reduced | History |
| ARDXArdelyx, Inc. | COM | 60,000 | $306.0K | 0.2% | −20,000−25.0% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 7,000 | $300.4K | 0.2% | −3,000−30.0% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 2,500 | $292.7K | 0.2% | −2,500−50.0% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 3,000 | $285.5K | 0.2% | −1,968−39.6% | Reduced | History |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 6,000 | $279.1K | 0.1% | 00.0% | Unchanged | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 5,000 | $272.7K | 0.1% | −4,500−47.4% | Reduced | History |
| ZYMEZymeworks Inc. | COM | 10,000 | $261.4K | 0.1% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 692 | $257.2K | 0.1% | +692 | New | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 18,000 | $254.7K | 0.1% | −53,000−74.6% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 4,200 | $253.5K | 0.1% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 1,000 | $244.8K | 0.1% | −1,845−64.9% | Reduced | History |
| AVBPArriVent BioPharma, Inc. | COM | 7,041 | $244.6K | 0.1% | +7,041 | New | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,500 | $243.7K | 0.1% | −2,500−50.0% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 971 | $234.0K | 0.1% | +971 | New | History |
| KODKodiak Sciences Inc. | COM | 6,000 | $233.8K | 0.1% | −4,000−40.0% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 1,200 | $224.7K | 0.1% | +1,200 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 3,000 | $223.4K | 0.1% | −3,000−50.0% | Reduced | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 2,000 | $222.1K | 0.1% | +2,000 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 8,463 | $217.7K | 0.1% | +8,463 | New | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 2,600 | $211.9K | 0.1% | +2,600 | New | History |
| SRRKScholar Rock Holding Corp | COM | 3,827 | $210.5K | 0.1% | +3,827 | New | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 5,000 | $203.2K | 0.1% | −1,500−23.1% | Reduced | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 10,838 | $194.7K | 0.1% | 00.0% | Unchanged | History |
| CTMXCytomX Therapeutics, Inc. | COM | 39,400 | $147.8K | 0.1% | +39,400 | New | History |
| OCULOcular Therapeutix, Inc | COM | 15,000 | $147.3K | 0.1% | 00.0% | Unchanged | History |
| EYPTEyePoint, Inc. | COM NEW | 10,000 | $143.0K | 0.1% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 13,000 | $140.8K | 0.1% | 00.0% | Unchanged | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 10,000 | $125.1K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (14)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| SERASera Prognostics, Inc. | CLASS A COM | 2,396,685 | $4.87M | 3.4% | History |
| TYRATyra Biosciences, Inc. | COM | 16,000 | $612.8K | 0.4% | History |
| CYTKCytokinetics Inc | COM NEW | 8,300 | $547.1K | 0.4% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 15,000 | $507.4K | 0.4% | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 1,500 | $483.3K | 0.3% | History |
| INBXInhibrx Biosciences, Inc. | COM | 6,927 | $465.7K | 0.3% | History |
| ERASErasca, Inc. | COM | 17,327 | $280.4K | 0.2% | History |
| CELCCelcuity Inc. | COM | 2,000 | $228.3K | 0.2% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 10,795 | $217.3K | 0.2% | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 12,000 | $217.1K | 0.2% | History |
| APGEApogee Therapeutics, Inc. | COM | 2,500 | $210.4K | 0.1% | History |
| UTHRUnited Therapeutics Corp | COM | 350 | $207.5K | 0.1% | History |
| SMMTSummit Therapeutics Inc. | COM | 10,223 | $193.8K | 0.1% | History |
| CMPXCompass Therapeutics, Inc. | COM | 30,000 | $158.7K | 0.1% | History |